This patent application relates to a transdermal therapeutic system (TTS) that comprises a Rotigotine-containing cement layer, characterized in that the cement layer contains a hot-meltable adhesive in which Rotigotine as the active substance is dispersed and partly or completely dissolved.The patent application further relates to the use of Rotigotine in the production of the cement layer of a TTS by a hot-melt method.